When selecting a contract development and manufacturing organization (CDMO) to partner with, pharmaceutical and biotechnology companies must consider several key […]

Partnering with Contract Development and Manufacturing Organizations (CDMOs) has become a strategic imperative for pharmaceutical and biotech companies seeking to

Navigating the world of biosimilars is no small feat. For business professionals in the biopharmaceutical industry, interacting with regulatory agencies

A well-crafted drug patent strategy can be the difference between market dominance and obscurity. For business professionals in this space,

How pharmaceutical companies navigate patent cliffs to sustain profitability and growth Introduction: The Patent Cliff Phenomenon Explained The pharmaceutical industry

The Russian pharmaceutical industry stands at a critical juncture, balancing domestic production ambitions with global geopolitical and economic pressures. Valued

The pharmaceutical industry is undergoing significant changes, particularly in emerging markets. These markets, characterized by large populations, growing prosperity, and

Patent litigation represents a significant financial burden for pharmaceutical companies, with costs potentially reaching millions of dollars per case. Effectively

Launching a generic drug isn’t just about hitting the market—it’s about dominating it. In an industry where competition is fierce,